SMTL ID : 6ngd.1

Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(5-(3-(dimethylamino)propyl)-2,3,4-trifluorophenethyl)-4-methylpyridin-2-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-dimer

Ligands

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 18 residues within 4Å: Chain A: W.113, A.116, R.118, C.119, V.120, G.121, S.161, F.288, S.289, G.290, W.291, M.293, E.296, W.382, F.408, Y.410 Ligands: H4B.2, KMS.3 19 PLIP interactions: 19 interactions with chain A, Hydrophobic interactions: A:W.113, A:W.113, A:W.113, A:A.116, A:R.118, A:F.288, A:F.288, A:F.288, A:F.288, A:W.291, A:E.296, A:W.382, A:W.382, A:F.408, A:F.408 Water bridges: A:E.296, A:R.300 pi-Stacking: A:W.113 Metal complexes: A:C.119 HEM.8: 18 residues within 4Å: Chain B: W.113, A.116, R.118, C.119, V.120, G.121, S.161, F.288, S.289, G.290, W.291, M.293, E.296, W.382, F.408, Y.410 Ligands: H4B.9, KMS.10 17 PLIP interactions: 17 interactions with chain B, Hydrophobic interactions: B:W.113, B:W.113, B:W.113, B:A.116, B:V.120, B:F.288, B:F.288, B:F.288, B:W.291, B:E.296, B:W.382, B:W.382, B:F.408, B:F.408 Hydrogen bonds: B:Y.410 pi-Stacking: B:W.113 Metal complexes: B:C.119

2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)

H4B.2: 12 residues within 4Å: Chain A: S.38, M.40, R.300, V.381, W.382 Chain B: W.380, F.395, H.396, Q.397, E.398 Ligands: HEM.1, KMS.3 12 PLIP interactions: 2 interactions with chain B, 10 interactions with chain A Hydrophobic interactions: B:E.398 Water bridges: B:H.396, A:S.38, A:W.382 Hydrogen bonds: A:R.300, A:R.300, A:V.381, A:W.382 pi-Stacking: A:W.382, A:W.382 pi-Cation interactions: A:W.382, A:W.382 H4B.9: 12 residues within 4Å: Chain A: W.380, F.395, H.396, Q.397, E.398 Chain B: S.38, M.40, R.300, V.381, W.382 Ligands: HEM.8, KMS.10 12 PLIP interactions: 11 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:R.300, B:V.381, B:W.382 Water bridges: B:S.38, B:R.300, B:R.300, B:R.300, B:W.382 pi-Stacking: B:W.382, B:W.382 pi-Cation interactions: B:W.382 Hydrophobic interactions: A:E.398

2 x KMS: 6-(2-{5-[3-(dimethylamino)propyl]-2,3,4-trifluorophenyl}ethyl)-4-methylpyridin-2-amine(Non-covalent)

KMS.3: 16 residues within 4Å: Chain A: M.40, Q.182, R.185, Y.266, P.269, V.271, F.288, S.289, G.290, W.291, Y.292, E.296, W.382 Ligands: HEM.1, H4B.2, GOL.4 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:P.269, A:P.269, A:V.271, A:F.288 Hydrogen bonds: A:M.293, A:E.296 KMS.10: 14 residues within 4Å: Chain B: M.40, Q.182, R.185, Y.266, P.269, V.271, F.288, G.290, W.291, Y.292, M.293, E.296 Ligands: HEM.8, H4B.9 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:Q.182, B:P.269, B:V.271, B:F.288 Hydrogen bonds: B:M.293, B:E.296

4 x GOL: GLYCEROL(Non-functional Binders)

GOL.4: 7 residues within 4Å: Chain A: R.300, D.304, S.306 Chain B: W.10, E.11, H.396 Ligands: KMS.3 6 PLIP interactions: 3 interactions with chain B, 3 interactions with chain A Hydrogen bonds: B:W.10, B:H.396, A:R.300, A:D.304 Water bridges: B:E.11, A:N.305 GOL.5: 3 residues within 4Å: Chain A: Q.68, R.114, R.373 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:Q.68, A:R.373 Water bridges: A:K.23, A:Q.68, A:Q.68, A:R.114, A:R.114, A:T.405 GOL.6: 6 residues within 4Å: Chain A: I.106, K.110, S.126, L.128, Q.129, V.130 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:K.110, A:S.126, A:L.128, A:V.130, A:V.130 Water bridges: A:Q.129 GOL.11: 2 residues within 4Å: Chain B: Q.68, R.373 7 PLIP interactions: 7 interactions with chain B Hydrogen bonds: B:Q.68, B:R.373 Water bridges: B:K.23, B:Q.68, B:Q.68, B:R.114, B:T.405

1 x ZN: ZINC ION(Non-covalent)

ZN.7: 4 residues within 4Å: Chain A: C.30, C.35 Chain B: C.30, C.35 4 PLIP interactions: 2 interactions with chain B, 2 interactions with chain A Metal complexes: B:C.30, B:C.35, A:C.30, A:C.35

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Do, H.T. et al., Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold. J. Med. Chem. (2019)

Release Date

2019-03-13

Peptides

Nitric oxide synthase, brain: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Nitric oxide synthase, brain

Related Entries With Identical Sequence